JUTREVE Trademark

Trademark Overview

On Friday, February 11, 2011, a trademark application was filed for JUTREVE with the United States Patent and Trademark Office. The USPTO has given the JUTREVE trademark a serial number of 85239668. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 22, 2014. This trademark is owned by Glaxo Group Limited. The JUTREVE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological,gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
jutreve

General Information

Serial Number85239668
Word MarkJUTREVE
Filing DateFriday, February 11, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 22, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 21, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological,gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 16, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, September 22, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, September 22, 2014ABANDONMENT - NO USE STATEMENT FILED
Tuesday, February 25, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, February 22, 2014EXTENSION 5 GRANTED
Tuesday, February 11, 2014EXTENSION 5 FILED
Tuesday, February 11, 2014TEAS EXTENSION RECEIVED
Tuesday, September 10, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 9, 2013EXTENSION 4 GRANTED
Monday, August 12, 2013EXTENSION 4 FILED
Friday, September 6, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 12, 2013TEAS EXTENSION RECEIVED
Monday, March 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 6, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 5, 2013EXTENSION 3 GRANTED
Monday, February 4, 2013EXTENSION 3 FILED
Monday, February 4, 2013TEAS EXTENSION RECEIVED
Thursday, August 23, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 22, 2012EXTENSION 2 GRANTED
Monday, August 13, 2012EXTENSION 2 FILED
Wednesday, August 22, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 13, 2012TEAS EXTENSION RECEIVED
Thursday, January 26, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 24, 2012EXTENSION 1 GRANTED
Tuesday, January 24, 2012EXTENSION 1 FILED
Tuesday, January 24, 2012TEAS EXTENSION RECEIVED
Tuesday, August 16, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 21, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 21, 2011PUBLISHED FOR OPPOSITION
Thursday, May 19, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, May 19, 2011ASSIGNED TO LIE
Thursday, May 5, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 5, 2011EXAMINER'S AMENDMENT ENTERED
Thursday, May 5, 2011NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, May 5, 2011EXAMINERS AMENDMENT E-MAILED
Thursday, May 5, 2011EXAMINERS AMENDMENT -WRITTEN
Thursday, April 28, 2011ASSIGNED TO EXAMINER
Wednesday, February 16, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, February 15, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

jutreve pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological